These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 39010313)

  • 41. Intrafamilial phenotypic heterogeneity in a Taiwanese family with a MAPT p.R5H mutation: a case report and literature review.
    Lin HC; Lin CH; Chen PL; Cheng SJ; Chen PH
    BMC Neurol; 2017 Sep; 17(1):186. PubMed ID: 28923025
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Longitudinal multimodal MRI as prognostic and diagnostic biomarker in presymptomatic familial frontotemporal dementia.
    Jiskoot LC; Panman JL; Meeter LH; Dopper EGP; Donker Kaat L; Franzen S; van der Ende EL; van Minkelen R; Rombouts SARB; Papma JM; van Swieten JC
    Brain; 2019 Jan; 142(1):193-208. PubMed ID: 30508042
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 11C-CFT-PET in Presymptomatic FTDP-17: A Potential Biomarker Predicting Onset.
    Wu L; Liu J; Feng X; Dong J; Qin W; Liu Y; Wang J; Lu J; Chen K; Wang Y; Jia J
    J Alzheimers Dis; 2018; 61(2):613-618. PubMed ID: 29226866
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Familial early onset frontotemporal dementia caused by a novel S356T MAPT mutation, initially diagnosed as schizophrenia.
    Momeni P; Wickremaratchi MM; Bell J; Arnold R; Beer R; Hardy J; Revesz T; Neal JW; Morris HR
    Clin Neurol Neurosurg; 2010 Dec; 112(10):917-20. PubMed ID: 20708332
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations.
    Bouzigues A; Russell LL; Peakman G; Bocchetta M; Greaves CV; Convery RS; Todd E; Rowe JB; Borroni B; Galimberti D; Tiraboschi P; Masellis M; Tartaglia MC; Finger E; van Swieten JC; Seelaar H; Jiskoot L; Sorbi S; Butler CR; Graff C; Gerhard A; Langheinrich T; Laforce R; Sanchez-Valle R; de Mendonça A; Moreno F; Synofzik M; Vandenberghe R; Ducharme S; Le Ber I; Levin J; Danek A; Otto M; Pasquier F; Santana I; Rohrer JD;
    J Neurol; 2022 Aug; 269(8):4322-4332. PubMed ID: 35348856
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic Accuracy of Amyloid versus
    Lesman-Segev OH; La Joie R; Iaccarino L; Lobach I; Rosen HJ; Seo SW; Janabi M; Baker SL; Edwards L; Pham J; Olichney J; Boxer A; Huang E; Gorno-Tempini M; DeCarli C; Hepker M; Hwang JL; Miller BL; Spina S; Grinberg LT; Seeley WW; Jagust WJ; Rabinovici GD
    Ann Neurol; 2021 Feb; 89(2):389-401. PubMed ID: 33219525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Frontal variant of Alzheimer's disease with asymmetric presentation mimicking frontotemporal dementia: Case report and literature review.
    Li CH; Fan SP; Chen TF; Chiu MJ; Yen RF; Lin CH
    Brain Behav; 2020 Mar; 10(3):e01548. PubMed ID: 31989779
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two pathologically confirmed cases of novel mutations in the MAPT gene causing frontotemporal dementia.
    Shafei R; Woollacott IOC; Mummery CJ; Bocchetta M; Guerreiro R; Bras J; Warren JD; Lashley T; Jaunmuktane Z; Rohrer JD
    Neurobiol Aging; 2020 Mar; 87():141.e15-141.e20. PubMed ID: 31870644
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical features and biomarkers of semantic variant primary progressive aphasia with MAPT mutation.
    Xu J; Xia Y; Meng M; Liu F; Che P; Zhang Y; Wang Y; Cai L; Qin W; Zhang N
    Alzheimers Res Ther; 2023 Jan; 15(1):21. PubMed ID: 36707904
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Frontotemporal dementia-associated N279K tau mutant disrupts subcellular vesicle trafficking and induces cellular stress in iPSC-derived neural stem cells.
    Wren MC; Zhao J; Liu CC; Murray ME; Atagi Y; Davis MD; Fu Y; Okano HJ; Ogaki K; Strongosky AJ; Tacik P; Rademakers R; Ross OA; Dickson DW; Wszolek ZK; Kanekiyo T; Bu G
    Mol Neurodegener; 2015 Sep; 10():46. PubMed ID: 26373282
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Frontotemporal Dementia-Parkinsonism Due to
    Bhattacharjee S; Kobylecki C
    Tremor Other Hyperkinet Mov (N Y); 2023; 13():35. PubMed ID: 37746582
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    Liu FT; Lu JY; Li XY; Jiao FY; Chen MJ; Yao RX; Liang XN; Ju ZZ; Ge JJ; Li G; Shen B; Wu P; Song J; Li J; Sun YM; Wu JJ; Yen TC; Luo JF; Zhao QH; Zuo C; Wang J;
    Mov Disord; 2023 Apr; 38(4):579-588. PubMed ID: 36750757
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer Disease.
    Zheng L; Rubinski A; Denecke J; Luan Y; Smith R; Strandberg O; Stomrud E; Ossenkoppele R; Svaldi DO; Higgins IA; Shcherbinin S; Pontecorvo MJ; Hansson O; Franzmeier N; Ewers M;
    Ann Neurol; 2024 Feb; 95(2):274-287. PubMed ID: 37837382
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An optimized reference tissue method for quantification of tau protein depositions in diverse neurodegenerative disorders by PET with
    Tagai K; Ikoma Y; Endo H; Debnath OB; Seki C; Matsuoka K; Matsumoto H; Oya M; Hirata K; Shinotoh H; Takahata K; Kurose S; Sano Y; Ono M; Shimada H; Kawamura K; Zhang MR; Takado Y; Higuchi M
    Neuroimage; 2022 Dec; 264():119763. PubMed ID: 36427751
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel P397S MAPT variant associated with late onset and slow progressive frontotemporal dementia.
    Borrego-Écija S; Antonell A; Puig-Butillé JA; Pericot I; Prat-Bravo C; Abellan-Vidal MT; Mallada J; Olives J; Falgàs N; Oliva R; Lladó A; Sánchez-Valle R
    Ann Clin Transl Neurol; 2019 Aug; 6(8):1559-1565. PubMed ID: 31402617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Frontal Variant of Alzheimer Disease Differentiated From Frontotemporal Dementia Using in Vivo Amyloid and Tau Imaging.
    Paquin V; Therriault J; Pascoal TA; Rosa-Neto P; Gauthier S
    Cogn Behav Neurol; 2020 Dec; 33(4):288-293. PubMed ID: 33264158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.
    Forrest SL; Kril JJ; Stevens CH; Kwok JB; Hallupp M; Kim WS; Huang Y; McGinley CV; Werka H; Kiernan MC; Götz J; Spillantini MG; Hodges JR; Ittner LM; Halliday GM
    Brain; 2018 Feb; 141(2):521-534. PubMed ID: 29253099
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated With MAPT, GRN, and C9orf72 Pathogenic Variants.
    Staffaroni AM; Goh SM; Cobigo Y; Ong E; Lee SE; Casaletto KB; Wolf A; Forsberg LK; Ghoshal N; Graff-Radford NR; Grossman M; Heuer HW; Hsiung GR; Kantarci K; Knopman DS; Kremers WK; Mackenzie IR; Miller BL; Pedraza O; Rascovsky K; Tartaglia MC; Wszolek ZK; Kramer JH; Kornak J; Boeve BF; Boxer AL; Rosen HJ;
    JAMA Netw Open; 2020 Oct; 3(10):e2022847. PubMed ID: 33112398
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals.
    Tosun D; Landau S; Aisen PS; Petersen RC; Mintun M; Jagust W; Weiner MW;
    Brain; 2017 May; 140(5):1499-1512. PubMed ID: 28334939
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterizing the Clinical Features and Atrophy Patterns of
    Young AL; Bocchetta M; Russell LL; Convery RS; Peakman G; Todd E; Cash DM; Greaves CV; van Swieten J; Jiskoot L; Seelaar H; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Otto M; Sorbi S; Williams SCR; Alexander DC; Rohrer JD;
    Neurology; 2021 Aug; 97(9):e941-e952. PubMed ID: 34158384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.